{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:50:08Z","timestamp":1783018208755,"version":"3.54.6"},"reference-count":50,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.2967\/jnumed.117.200048","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:40:39Z","timestamp":1508460039000},"page":"334-339","source":"Crossref","is-referenced-by-count":66,"title":["<sup>68<\/sup>Ga-NOTA-Functionalized Ubiquicidin: Cytotoxicity, Biodistribution, Radiation Dosimetry, and First-in-Human PET\/CT Imaging of Infections"],"prefix":"10.2967","volume":"59","author":[{"given":"Thomas","family":"Ebenhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike M.","family":"Sathekge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thabo","family":"Lengana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Koole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gheysens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thavendran","family":"Govender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan R.","family":"Zeevaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"2021051712114272000_59.2.334.1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2008.08.002"},{"key":"2021051712114272000_59.2.334.2","doi-asserted-by":"publisher","DOI":"10.1007\/s000110050725"},{"key":"2021051712114272000_59.2.334.3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MNM.0b013e3283528a7c","article-title":"Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals","volume":"33","author":"Sathekge","year":"2012","journal-title":"Nucl Med Commun."},{"key":"2021051712114272000_59.2.334.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0762-9"},{"key":"2021051712114272000_59.2.334.5","doi-asserted-by":"publisher","DOI":"10.1021\/bc4003037"},{"key":"2021051712114272000_59.2.334.6","first-page":"236","article-title":"Receptor targeting agents for imaging inflammation\/infection: where are we now?","volume":"50","author":"Signore","year":"2006","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"2021051712114272000_59.2.334.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7799(02)00032-X"},{"key":"2021051712114272000_59.2.334.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2008.08.004"},{"key":"2021051712114272000_59.2.334.9","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-27994-2_11"},{"key":"2021051712114272000_59.2.334.10","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32830160fd"},{"key":"2021051712114272000_59.2.334.11","doi-asserted-by":"crossref","first-page":"867381","DOI":"10.1155\/2014\/867381","article-title":"Antimicrobial peptides: their role as infection-selective tracers for molecular imaging","volume":"2014","author":"Ebenhan","year":"2014","journal-title":"BioMed Res Int."},{"key":"2021051712114272000_59.2.334.12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jlb.66.3.423","article-title":"Ubiquicidin, a novel murine microbicidal protein present in the cytosolic fraction of macrophages","volume":"66","author":"Hiemstra","year":"1999","journal-title":"J Leukoc Biol."},{"key":"2021051712114272000_59.2.334.13","first-page":"321","article-title":"99mTc-labeled UBI29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus","volume":"45","author":"Nibbering","year":"2004","journal-title":"J Nucl Med."},{"key":"2021051712114272000_59.2.334.14","first-page":"567","article-title":"Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial","volume":"46","author":"Akhtar","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712114272000_59.2.334.15","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2174\/138955708785740670","article-title":"The use of technetium-99m radiolabeled human antimicrobial peptides for infection specific imaging","volume":"8","author":"Brouwer","year":"2008","journal-title":"Mini Rev Med Chem."},{"key":"2021051712114272000_59.2.334.16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cmmi.232","article-title":"68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals","volume":"3","author":"Fani","year":"2008","journal-title":"Contrast Media Mol Imaging."},{"key":"2021051712114272000_59.2.334.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2008.03.002"},{"key":"2021051712114272000_59.2.334.18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/thno.7447","article-title":"Prospective of 68Ga-radiopharmaceutical development","volume":"4","author":"Velikyan","year":"2013","journal-title":"Theranostics."},{"key":"2021051712114272000_59.2.334.19","doi-asserted-by":"publisher","DOI":"10.2174\/157340611796799195"},{"key":"2021051712114272000_59.2.334.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2014.02.001"},{"key":"2021051712114272000_59.2.334.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.128397"},{"key":"2021051712114272000_59.2.334.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2006.05.022"},{"key":"2021051712114272000_59.2.334.23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2012.03.027","article-title":"Synthesis and molecular modelling studies of novel carbapeptide analogs for inhibition of HIV-1 protease","volume":"53","author":"Pawar","year":"2012","journal-title":"Eur J Med Chem."},{"key":"2021051712114272000_59.2.334.24","doi-asserted-by":"crossref","first-page":"284354","DOI":"10.1155\/2015\/284354","article-title":"Synthesis, 68Ga-radiolabeling and preliminary in vivo assessment of a depsipeptide-derived compound as a potential PET\/CT infection imaging agent","volume":"2015","author":"Mokaleng","year":"2015","journal-title":"BioMed Res Int."},{"key":"2021051712114272000_59.2.334.25","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-957563"},{"key":"2021051712114272000_59.2.334.26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00081-09"},{"key":"2021051712114272000_59.2.334.27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11307-016-1014-1","article-title":"Evaluation of a flexible NOTA-RGD kit solution using gallium-68 from different 68Ge\/68Ga-generators: pharmacokinetics and biodistribution in nonhuman primates and demonstration of solitary pulmonary nodule imaging in humans","volume":"19","author":"Ebenhan","year":"2017","journal-title":"Mol Imaging Biol."},{"key":"2021051712114272000_59.2.334.28","first-page":"1023","article-title":"OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712114272000_59.2.334.29","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2014.07.005"},{"key":"2021051712114272000_59.2.334.30","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050488"},{"key":"2021051712114272000_59.2.334.31","first-page":"167","article-title":"New concepts in infection\/inflammation imaging","volume":"45","author":"Rennen","year":"2001","journal-title":"Q J Nucl Med."},{"key":"2021051712114272000_59.2.334.32","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/jps.21034","article-title":"The pharmacology of radiolabeled cationic antimicrobial peptides","volume":"97","author":"Brouwer","year":"2008","journal-title":"J Pharm Sci."},{"key":"2021051712114272000_59.2.334.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.12.004"},{"key":"2021051712114272000_59.2.334.34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3664"},{"key":"2021051712114272000_59.2.334.35","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00196-07"},{"key":"2021051712114272000_59.2.334.36","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161265"},{"key":"2021051712114272000_59.2.334.37","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-008-0553-z"},{"key":"2021051712114272000_59.2.334.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8051(03)00054-4"},{"key":"2021051712114272000_59.2.334.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2003.10.005"},{"key":"2021051712114272000_59.2.334.40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11307-016-0983-4","article-title":"Radiolabeling and preliminary evaluation of Ga-68 labeled NODAGA-ubiquicidin fragments for prospective infection imaging","volume":"19","author":"Bhatt","year":"2017","journal-title":"Mol Imaging Biol."},{"key":"2021051712114272000_59.2.334.41","doi-asserted-by":"publisher","DOI":"10.1093\/ilar\/ilt049"},{"key":"2021051712114272000_59.2.334.42","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0853-7"},{"key":"2021051712114272000_59.2.334.43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3413\/Nukmed-0667-14-05","article-title":"Dosimetric measurements of 68Ga-high affinity DOTATATE: twins in spirit\u2014part III","volume":"53","author":"Hartmann","year":"2014","journal-title":"Nuklearmedizin."},{"key":"2021051712114272000_59.2.334.44","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/44\/2\/021"},{"key":"2021051712114272000_59.2.334.45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.nucmedbio.2008.11.003","article-title":"Clinical evaluation of antimicrobial peptide [99mTc\/Tricine\/HYNIC0]ubiquicidin 29-41 as a human-specific infection imaging agent","volume":"36","author":"Gandomkar","year":"2009","journal-title":"Nucl Med Biol."},{"key":"2021051712114272000_59.2.334.46","doi-asserted-by":"publisher","DOI":"10.2967\/jnm565abs"},{"key":"2021051712114272000_59.2.334.47","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s11307-016-0946-9","article-title":"Biodistribution and radiation dosimetry of the Enterobacteriaceae-specific imaging probe [18F]fluorodeoxysorbitol determined by PET\/CT in healthy human volunteers","volume":"18","author":"Zhu","year":"2016","journal-title":"Mol Imaging Biol."},{"key":"2021051712114272000_59.2.334.48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3009815"},{"key":"2021051712114272000_59.2.334.49","first-page":"999","article-title":"Impact of animal handling on the results of 18F-FDG PET studies in mice","volume":"47","author":"Fueger","year":"2006","journal-title":"J Nucl Med."},{"key":"2021051712114272000_59.2.334.50","doi-asserted-by":"publisher","DOI":"10.1258\/la.2012.011173"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.117.200048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:23:38Z","timestamp":1621283018000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.117.200048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,1]]},"published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.2967\/jnumed.117.200048"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.117.200048","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}